Lipid phosphatase SAC1 suppresses hepatocellular carcinoma metastasis by attenuating YAP-mediated integrin expression

Metastasis is the primary cause of recurrence and mortality in hepatocellular carcinoma (HCC); however, the underlying molecular mechanisms remain to be fully elucidated. SAC1/SACM1L, a SAC1-like phosphoinositide phosphatase that dephosphorylates phosphatidylinositol-4-phosphate (PI4P), is downregulated in metastatic breast and prostate cancers. However, its role in HCC tumorigenesis and metastasis remains unexplored. The potential role of SAC1 in HCC tumorigenesis/metastasis was investigated in vitro using HCC cell lines and in vivo using BALB/c nude mouse models established via tail vein injection or orthotopic liver implantation of HCC cells. Our study revealed that decreased SAC1 levels correlate with tumor metastasis and poor prognosis in patients with HCC. Silencing of SAC1 did not significantly affect proliferation but promoted migration and invasion in MHCC97H and PLC/PRF/5 HCC cells. Conversely, SAC1 overexpression suppressed these metastatic phenotypes. Stable overexpression of SAC1 in MHCC97H cells significantly reduced lung metastatic burden in BALB/c nude mice following tail vein injection or orthotopic liver implantation. Mechanistically, SAC1 suppresses HCC metastasis by downregulating the expression of integrins, including ITGA2, ITGAV, and ITGB6. SAC1 attenuates YAP-mediated integrin expression via a two-level mechanism: it hydrolyzes PI4P to activate the NF2/Hippo signaling axis, leading to YAP phosphorylation and inhibition of its nuclear localization; SAC1 also facilitates the interaction between 14-3-3 proteins and phosphorylated YAP, thereby promoting its cytoplasmic retention and inhibiting integrin expression. Collectively, our findings establish that SAC1 functions as a novel inhibitor of HCC metastasis through attenuating YAP-mediated integrin expression, suggesting its potential as both a potential prognostic biomarker and a candidate therapeutic target for metastatic HCC.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-15
DOI
https://doi.org/10.1186/s12967-026-09235-2
Primary Topic
Hippo pathway signaling and YAP/TAZ
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lipid phosphatase SAC1 suppresses hepatocellular carcinoma metastasis by attenuating YAP-mediated integrin expression

Wanyu Deng, Sichen Luo, Yong Lin, Hecun Zou et al.
Journal of Translational Medicine
Hippo pathway signaling and YAP/TAZ
article

Lipid phosphatase SAC1 suppresses hepatocellular carcinoma metastasis by attenuating YAP-mediated integrin expression

Wanyu Deng, Sichen Luo, Yong Lin, Hecun Zou, Dan Xu, Ning Jiang, Haoran Tang, Mengji Lu, Hongyu Deng, Wen Shu, Beinu Guo, Tianyu Chen, Qian Liu, Zhen Wei, Mengting Liu, Jiang Min, Jie Xia
article en

Abstract

Metastasis is the primary cause of recurrence and mortality in hepatocellular carcinoma (HCC); however, the underlying molecular mechanisms remain to be fully elucidated. SAC1/SACM1L, a SAC1-like phosphoinositide phosphatase that dephosphorylates phosphatidylinositol-4-phosphate (PI4P), is downregulated in metastatic breast and prostate cancers. However, its role in HCC tumorigenesis and metastasis remains unexplored. The potential role of SAC1 in HCC tumorigenesis/metastasis was investigated in vitro using HCC cell lines and in vivo using BALB/c nude mouse models established via tail vein injection or orthotopic liver implantation of HCC cells. Our study revealed that decreased SAC1 levels correlate with tumor metastasis and poor prognosis in patients with HCC. Silencing of SAC1 did not significantly affect proliferation but promoted migration and invasion in MHCC97H and PLC/PRF/5 HCC cells. Conversely, SAC1 overexpression suppressed these metastatic phenotypes. Stable overexpression of SAC1 in MHCC97H cells significantly reduced lung metastatic burden in BALB/c nude mice following tail vein injection or orthotopic liver implantation. Mechanistically, SAC1 suppresses HCC metastasis by downregulating the expression of integrins, including ITGA2, ITGAV, and ITGB6. SAC1 attenuates YAP-mediated integrin expression via a two-level mechanism: it hydrolyzes PI4P to activate the NF2/Hippo signaling axis, leading to YAP phosphorylation and inhibition of its nuclear localization; SAC1 also facilitates the interaction between 14-3-3 proteins and phosphorylated YAP, thereby promoting its cytoplasmic retention and inhibiting integrin expression. Collectively, our findings establish that SAC1 functions as a novel inhibitor of HCC metastasis through attenuating YAP-mediated integrin expression, suggesting its potential as both a potential prognostic biomarker and a candidate therapeutic target for metastatic HCC.

Journal of Translational Medicine
Shangrao Normal University (CN), Central South University (CN), Hunan Cancer Hospital (CN), Essen University Hospital (DE), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), University of Duisburg-Essen (DE), Chongqing Medical University (CN)
Hippo pathway signaling and YAP/TAZ
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon